Area of research
Hematology · Genetics
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Mesenchymal stem cell research, Acute Myeloid Leukemia Research, and Virus-based gene therapy research.
Allogeneic hematopoietic cell transplantation for aplastic anemia: a single institution experience across 6 decades.
Donor-derived del[20q] following allogeneic-hematopoietic cell transplantation: a case with 26-year follow-up and literature review.
Subsequent cancers following non-myeloablative conditioning for allogeneic hematopoietic cell transplantation.
Subsequent Cancers following Non-myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation
Characterization of clonal dynamics using duplex sequencing in donor-recipient pairs decades after hematopoietic cell transplantation.
Allogeneic bone marrow transplantation for aplastic anemia.
Comparison of reduced intensity and nonmyeloablative conditioning for adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation in first or second remission.
Impact of Donor Statin Treatment on Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.
Utility of the Treatment-Related Mortality (TRM) score to predict outcomes of adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation.
Cancers after HLA-matched related bone marrow transplantation for aplastic anemia.
Transcutaneous ultrasound-mediated gene delivery into canine livers achieves therapeutic levels of factor VIII expression.
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high-grade B-cell lymphoma.
Commentary on the 1962 Transfusion paper by Don Thomas and Joe Ferrebee.
Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.
EASIX and mortality after allogeneic stem cell transplantation.
Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML.
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen–mismatched donors
Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model.
EASIX and mortality after allogeneic stem cell transplantation
Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial
Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation.
Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab
Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources
Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission.
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis
RNA Splicing Modulation Selectively Impairs Leukemia Stem Cell Maintenance in Secondary Human AML
It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)
Multi‐centre validation of the prognostic value of the haematopoietic cell transplantation‐ specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation